Turning Point Therapeutics, Inc.
Diaryl macrocycles as modulators of protein kinases

Abstract:

The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.